2024-04-012025-03-312025-03-31false14297197NORFOLK PELVIC HEALTH LTD.2025-08-2869109falseiso4217:GBPxbrli:pure142971972024-03-31142971972025-03-31142971972024-04-012025-03-31142971972023-01-20142971972024-03-31142971972023-01-212024-03-3114297197bus:SmallEntities2024-04-012025-03-3114297197bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114297197bus:FullAccounts2024-04-012025-03-3114297197bus:PrivateLimitedCompanyLtd2024-04-012025-03-3114297197core:WithinOneYear2025-03-3114297197core:AfterOneYear2025-03-3114297197core:WithinOneYear2024-03-3114297197core:AfterOneYear2024-03-3114297197core:ShareCapital2025-03-3114297197core:SharePremium2025-03-3114297197core:RevaluationReserve2025-03-3114297197core:OtherReservesSubtotal2025-03-3114297197core:RetainedEarningsAccumulatedLosses2025-03-3114297197core:ShareCapital2024-03-3114297197core:SharePremium2024-03-3114297197core:RevaluationReserve2024-03-3114297197core:OtherReservesSubtotal2024-03-3114297197core:RetainedEarningsAccumulatedLosses2024-03-3114297197core:LandBuildings2025-03-3114297197core:PlantMachinery2025-03-3114297197core:Vehicles2025-03-3114297197core:FurnitureFittings2025-03-3114297197core:OfficeEquipment2025-03-3114297197core:NetGoodwill2025-03-3114297197core:IntangibleAssetsOtherThanGoodwill2025-03-3114297197core:ListedExchangeTraded2025-03-3114297197core:UnlistedNon-exchangeTraded2025-03-3114297197core:LandBuildings2024-03-3114297197core:PlantMachinery2024-03-3114297197core:Vehicles2024-03-3114297197core:FurnitureFittings2024-03-3114297197core:OfficeEquipment2024-03-3114297197core:NetGoodwill2024-03-3114297197core:IntangibleAssetsOtherThanGoodwill2024-03-3114297197core:ListedExchangeTraded2024-03-3114297197core:UnlistedNon-exchangeTraded2024-03-3114297197core:LandBuildings2024-04-012025-03-3114297197core:PlantMachinery2024-04-012025-03-3114297197core:Vehicles2024-04-012025-03-3114297197core:FurnitureFittings2024-04-012025-03-3114297197core:OfficeEquipment2024-04-012025-03-3114297197core:NetGoodwill2024-04-012025-03-3114297197core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114297197core:ListedExchangeTraded2024-04-012025-03-3114297197core:UnlistedNon-exchangeTraded2024-04-012025-03-3114297197core:MoreThanFiveYears2024-04-012025-03-3114297197core:Non-currentFinancialInstruments2025-03-3114297197core:Non-currentFinancialInstruments2024-03-3114297197dpl:CostSales2024-04-012025-03-3114297197dpl:DistributionCosts2024-04-012025-03-3114297197core:LandBuildings2024-04-012025-03-3114297197core:PlantMachinery2024-04-012025-03-3114297197core:Vehicles2024-04-012025-03-3114297197core:FurnitureFittings2024-04-012025-03-3114297197core:OfficeEquipment2024-04-012025-03-3114297197dpl:AdministrativeExpenses2024-04-012025-03-3114297197core:NetGoodwill2024-04-012025-03-3114297197core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114297197dpl:GroupUndertakings2024-04-012025-03-3114297197dpl:ParticipatingInterests2024-04-012025-03-3114297197dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114297197core:ListedExchangeTraded2024-04-012025-03-3114297197dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114297197core:UnlistedNon-exchangeTraded2024-04-012025-03-3114297197dpl:CostSales2023-01-212024-03-3114297197dpl:DistributionCosts2023-01-212024-03-3114297197core:LandBuildings2023-01-212024-03-3114297197core:PlantMachinery2023-01-212024-03-3114297197core:Vehicles2023-01-212024-03-3114297197core:FurnitureFittings2023-01-212024-03-3114297197core:OfficeEquipment2023-01-212024-03-3114297197dpl:AdministrativeExpenses2023-01-212024-03-3114297197core:NetGoodwill2023-01-212024-03-3114297197core:IntangibleAssetsOtherThanGoodwill2023-01-212024-03-3114297197dpl:GroupUndertakings2023-01-212024-03-3114297197dpl:ParticipatingInterests2023-01-212024-03-3114297197dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-212024-03-3114297197core:ListedExchangeTraded2023-01-212024-03-3114297197dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-212024-03-3114297197core:UnlistedNon-exchangeTraded2023-01-212024-03-3114297197core:NetGoodwill2025-03-3114297197core:IntangibleAssetsOtherThanGoodwill2025-03-3114297197core:LandBuildings2025-03-3114297197core:PlantMachinery2025-03-3114297197core:Vehicles2025-03-3114297197core:FurnitureFittings2025-03-3114297197core:OfficeEquipment2025-03-3114297197core:AfterOneYear2025-03-3114297197core:WithinOneYear2025-03-3114297197core:ListedExchangeTraded2025-03-3114297197core:UnlistedNon-exchangeTraded2025-03-3114297197core:ShareCapital2025-03-3114297197core:SharePremium2025-03-3114297197core:RevaluationReserve2025-03-3114297197core:OtherReservesSubtotal2025-03-3114297197core:RetainedEarningsAccumulatedLosses2025-03-3114297197core:NetGoodwill2024-03-3114297197core:IntangibleAssetsOtherThanGoodwill2024-03-3114297197core:LandBuildings2024-03-3114297197core:PlantMachinery2024-03-3114297197core:Vehicles2024-03-3114297197core:FurnitureFittings2024-03-3114297197core:OfficeEquipment2024-03-3114297197core:AfterOneYear2024-03-3114297197core:WithinOneYear2024-03-3114297197core:ListedExchangeTraded2024-03-3114297197core:UnlistedNon-exchangeTraded2024-03-3114297197core:ShareCapital2024-03-3114297197core:SharePremium2024-03-3114297197core:RevaluationReserve2024-03-3114297197core:OtherReservesSubtotal2024-03-3114297197core:RetainedEarningsAccumulatedLosses2024-03-3114297197core:NetGoodwill2023-01-2014297197core:IntangibleAssetsOtherThanGoodwill2023-01-2014297197core:LandBuildings2023-01-2014297197core:PlantMachinery2023-01-2014297197core:Vehicles2023-01-2014297197core:FurnitureFittings2023-01-2014297197core:OfficeEquipment2023-01-2014297197core:AfterOneYear2023-01-2014297197core:WithinOneYear2023-01-2014297197core:ListedExchangeTraded2023-01-2014297197core:UnlistedNon-exchangeTraded2023-01-2014297197core:ShareCapital2023-01-2014297197core:SharePremium2023-01-2014297197core:RevaluationReserve2023-01-2014297197core:OtherReservesSubtotal2023-01-2014297197core:RetainedEarningsAccumulatedLosses2023-01-2014297197core:AfterOneYear2024-04-012025-03-3114297197core:WithinOneYear2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114297197core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114297197core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114297197core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114297197core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114297197core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114297197bus:Director12024-04-012025-03-3114297197bus:Director22024-04-012025-03-31

NORFOLK PELVIC HEALTH LTD.

Registered Number
14297197
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

NORFOLK PELVIC HEALTH LTD.
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Hannah Gray
Dr Thomas Gray

Registered Address

Cornerways Burnthouse Lane
Little Melton
Norwich
NR9 3NN

Registered Number

14297197 (England and Wales)
NORFOLK PELVIC HEALTH LTD.
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,518197
1,518197
Current assets
Debtors417,0659,746
Cash at bank and on hand3,570592
20,63510,338
Creditors amounts falling due within one year5(7,481)(2,798)
Net current assets (liabilities)13,1547,540
Total assets less current liabilities14,6727,737
Provisions for liabilities6(288)(49)
Net assets14,3847,688
Capital and reserves
Called up share capital22
Profit and loss account14,3827,686
Shareholders' funds14,3847,688
The financial statements were approved and authorised for issue by the Board of Directors on 28 August 2025, and are signed on its behalf by:
Dr Thomas Gray
Director
Registered Company No. 14297197
NORFOLK PELVIC HEALTH LTD.
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable. Turnover includes revenue earned from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Office Equipment253
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 24200200
Additions1,6241,624
At 31 March 251,8241,824
Depreciation and impairment
At 01 April 2433
Charge for year303303
At 31 March 25306306
Net book value
At 31 March 251,5181,518
At 31 March 24197197
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables5,6899,618
Other debtors10,664128
Prepayments and accrued income712-
Total17,0659,746
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security7,4812,096
Accrued liabilities and deferred income-702
Total7,4812,798
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)28849
Total28849